BioSpace News Archive

Pharm Country

Teva to Present at the 41st Annual J.P. Morgan Healthcare Conference

Teva Pharmaceutical Industries Ltd. announced that members of management will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023.

January 3, 2023
·
2 min read
Pharm Country

AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2023 Earnings Release

AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2023 on Wednesday, February 1, 2023, prior to the opening of trading on the New York Stock Exchange.

January 3, 2023
·
2 min read
Business

ADC Therapeutics Appoints Mohamed Zaki as Chief Medical Officer

ADC Therapeutics SA announced the appointment of industry veteran Mohamed Zaki, MD, PhD, as Chief Medical Officer, effective January 3, 2023. He will serve on the Company’s executive leadership team.

January 3, 2023
·
5 min read
Business

Mesa Labs Declares Quarterly Dividend - Jan 03, 2023

Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

January 3, 2023
·
2 min read
Genetown

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 03, 2023

Cullinan Oncology, Inc. announced that the compensation committee of the Company’s Board of Directors granted stock option awards to purchase an aggregate of 37,000 shares of its common stock to three employees outside Cullinan Oncology, Inc’s 2021 Stock Option and Incentive Plan.

January 3, 2023
·
2 min read
Genetown

CANbridge Consolidates Gene Therapy Portfolio

CANbridge Pharmaceuticals, Inc. announced that it has exercised its option to secure the exclusive global rights to develop, manufacture and commercialize a novel second-generation gene therapy to treat spinal muscular atrophy from UMass Chan Medical School.

January 3, 2023
·
7 min read
ITM to Present at the 41st Annual J.P. Morgan Healthcare Conference

ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced that CEO Steffen Schuster and CFO Dr. Klaus Maleck will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco.

January 3, 2023
·
2 min read